The use of biological markers in the diagnosis and follow-up of patients with multiple sclerosis.: Test of the five humours

被引:8
|
作者
Oehninger-Gatti, C [1 ]
Buzó, R [1 ]
Alcántara, JC [1 ]
Chouza, C [1 ]
Gómez, A [1 ]
Cibils, D [1 ]
Gordon-Firing, S [1 ]
机构
[1] Hosp Clin, Neurol Inst, Secc Enfermedades Desmielinizantes, Montevideo, Uruguay
关键词
cerebrospinal fluid; cetrulin rich basic myelin protein of the central nervous system; light chain imbalance; oligoclonal distribution of immunoglobulins multiple sclerosis; soluble interleukin-2 receptor;
D O I
10.33588/rn.3010.99367
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients and methods. We studied five biological fluids which were easily accessible to immunological examination (cerebrospinal fluid, plasma tears, saliva and urine) in 25 patients with multiple sclerosis, clinically definite according to the criteria of Cleveland, Ohio (1991) and tabulated according to the Kurztke's expanded disability status scale. The samples were obtained simultaneously during a clinical bout of the disease before any pharmacological or immunosuppressive treatment had been given. Results. The soluble interleukin-2 levels were significantly raised in at least three of these fluid's -always absent from the urine- when compared with normal controls The sensitivity and specificity of this determination for diagnosis of the condition was greater than that of other immunochemical parameters -oligoclonal distribution of immunoglobulins (specifically of IgG), imbalance of the light Kappa and Lambda chains and physiological studies (evoked potentials). The dosification and quantification of basic myelin protein of the central nervous system, rich in citruline in the urine, may be a parameter of progressiveness. Conclusion. This methodology (five humours test) may be used to establish an earlier more certain diagnosis of multiple sclerosis and also monitor its biological activity together with nuclear magnetic resonance with intravenous contrast.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
  • [1] Follow-up to a second generation genomic screen for multiple sclerosis.
    Kenealy, SJ
    Bradford, Y
    Schnetz-Boutaud, N
    Oksenberg, JR
    Hauser, SL
    Barcellos, LF
    Lincoln, RR
    Schmidt, S
    Pericak-Vance, MA
    Haines, JL
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 534 - 534
  • [2] The communication between astrocytes as a test in the follow-up of multiple sclerosis patients
    Cacabelos, P
    Prieto, JM
    Tabernero, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 108 - 108
  • [3] New biological markers in the diagnosis and follow-up of brucellosis
    Cagan, Eren
    Kizmaz, Muhammed Ali
    Simsek, Abdurrahman
    Akalin, Halis
    Oral, Haluk Barbaros
    Budak, Ferah
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 330 - 330
  • [4] USE OF EVOKED-POTENTIALS IN THE DIAGNOSIS AND FOLLOW-UP OF MULTIPLE-SCLEROSIS
    DRISLANE, FW
    CLINICAL NEUROSCIENCE, 1994, 2 (3-4) : 196 - 201
  • [5] Follow-up of hypertension in patients with multiple sclerosis
    Baghbanian, Seyed Mohammad
    IRANIAN JOURNAL OF NEUROLOGY, 2016, 15 (03) : 180 - 181
  • [6] BIOLOGICAL MARKERS FOR TUMORS OF THE TESTIS - THEIR USE IN DIAGNOSIS, PROGNOSIS AND FOLLOW-UP IN 200 CASES
    BELLET, D
    CAILLAUD, JM
    DROZ, JP
    DELARUE, JC
    BOHUON, C
    NOUVELLE PRESSE MEDICALE, 1981, 10 (40): : 3293 - 3297
  • [7] Sexual function in multiple sclerosis. A 5-year follow-up study
    Stenager, E
    Stenager, EN
    Jensen, K
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 17 (01): : 67 - 69
  • [8] New biological markers in diagnosis and follow-up of brucellosis cases
    Cagan, E.
    Kizmaz, M. A.
    Akalin, E. H.
    Oral, H. B.
    Tezcan, G.
    Budak, F.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (02)
  • [9] Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations
    Cruz, Andreia
    Pereira, Daniela
    Batista, Sonia
    ACTA MEDICA PORTUGUESA, 2024, 37 (01) : 53 - 63
  • [10] Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis
    Nistri, Riccardo
    Ianniello, Antonio
    Pozzilli, Valeria
    Gianni, Costanza
    Pozzilli, Carlo
    DIAGNOSTICS, 2024, 14 (11)